CSIMarket
 


Carlisle Companies Incorporated  (CSL)
Other Ticker:  
 
 

CSL's Income from Cont. Operations Growth by Quarter and Year

Carlisle Companies Incorporated's Income from Cont. Operations results by quarter and year




CSL Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 179.80 127.70 84.70
III Quarter September 216.90 255.20 113.00 102.30
II Quarter June 241.50 295.90 94.10 75.40
I Quarter March 99.60 194.30 52.20 61.80
FY   558.00 925.20 387.00 324.20



CSL Income from Cont. Operations third quarter 2023 Y/Y Growth Comment
Carlisle Companies Incorporated reported decline in Income from Cont. Operations in the third quarter 2023 by -15.01% to $ 216.90 millions, from the same quarter in 2022.
The contraction in the third quarter 2023 Carlisle Companies Incorporated's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations jump of 53.68%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 32 other companies have achieved higher Income from Cont. Operations growth. While Carlisle Companies Incorporated' s Income from Cont. Operations fall of -15.01% ranks overall at the positon no. 1236 in the third quarter 2023.




CSL Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 40.8 % 50.77 % -18.56 %
III Quarter September -15.01 % 125.84 % 10.46 % -26.56 %
II Quarter June -18.38 % 214.45 % 24.8 % -50.72 %
I Quarter March -48.74 % 272.22 % -15.53 % -20.16 %
FY   - 139.07 % 19.37 % -31.56 %

Financial Statements
Carlisle Companies Incorporated's third quarter 2023 Income from Cont. Operations $ 216.90 millions CSL's Income Statement
Carlisle Companies Incorporated's third quarter 2022 Income from Cont. Operations $ 255.20 millions Quarterly CSL's Income Statement
New: More CSL's historic Income from Cont. Operations Growth >>


CSL Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -29.55 % 13.01 % -17.2 %
III Quarter September -10.19 % -13.75 % 20.09 % 35.68 %
II Quarter June 142.47 % 52.29 % 80.27 % 22.01 %
I Quarter March -44.61 % 52.15 % -38.37 % -40.58 %
FY (Year on Year)   - 139.07 % 19.37 % -31.56 %




Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #85
Overall #1236

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
823.17 % 53.68 % -90.83 %
(Jun 30 2014)   (Jun 30 2013)
Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #85
Overall #1236
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
823.17 % 53.68 % -90.83 %
(Jun 30 2014)   (Jun 30 2013)

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Carlisle Companies Incorporated's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
834.15 % 34.72 % -85.17 %
(Sep 30 2013)  


CSL's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2023 Carlisle Companies Incorporated disclosed drop in Income from Cont. Operations sequentially by -10.19% to $ 216.90 millions, from $ 241.50 millions achived a quarter before.

As we evaluate current downturn at the III. Quarter, we should presume, that commonly III. Quarter 2023 results occur softer then in the preciding period, Robert  Brown, Medical Equipment & Supplies industry veteran from Toronto added.

Within Medical Equipment & Supplies industry 39 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Carlisle Companies Incorporated's Income from Cont. Operations growth quarter on quarter, overall rank is 1379.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #40
Healthcare Sector #98
Overall #1379
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #40
Healthcare Sector #98
Overall #1379
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
834.15 % 34.72 % -85.17 %
(Sep 30 2013)  


CSL's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2023 Carlisle Companies Incorporated disclosed drop in Income from Cont. Operations from the previous quarter by -10.19% to $ 216.90 millions, from $ 241.50 millions released in the previous quarter.

This is not big problem, as III. Quarter Income from Cont. Operations generally tend to dip in the III. Quarter Robert  Brown, Medical Equipment & Supplies industry veteran from Toronto noted.

Within Medical Equipment & Supplies industry 39 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Carlisle Companies Incorporated's Income from Cont. Operations growth quarter on quarter, overall rank is 1379.


Carlisle Companies Incorporated's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ 737.80 $ 776.10 $ 830.50 $ 925.20 $ 873.10
Y / Y Income from Cont. Operations Growth (TTM) -15.5 % 6.18 % 56.96 % 139.07 % 153.81 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 77 # 35 # 50 # 585 # 146
Seqeuential Income from Cont. Operations Change (TTM) -4.93 % -6.55 % -10.24 % 5.97 % 19.46 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 346 # 101 # 81 # 684 # 284




Cumulative Income from Cont. Operations growth Comment
For the 12 months ended Sep 30 2023 Carlisle Companies Incorporated reported a fall in Income from Cont. Operations by -15.5% year on year, to $738 millions, compare to the 6.18% growth at Jun 30 2023.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 35 to 77.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
153.81 %
21.76 %
-37.42 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 3
Overall # 77

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
153.81 %
21.76 %
-37.42 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 23
S&P 500 # 346
Cumulative Income from Cont. Operations growth Comment
For the 12 months ended Sep 30 2023 Carlisle Companies Incorporated reported a fall in Income from Cont. Operations by -15.5% year on year, to $738 millions, compare to the 6.18% growth at Jun 30 2023.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 35 to 77.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
153.81 %
21.76 %
-37.42 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 3
Overall # 77

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
153.81 %
21.76 %
-37.42 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 23
S&P 500 # 346




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
CSL's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for CSL's Competitors
Income from Cont. Operations Growth for Carlisle Companies Incorporated's Suppliers
Income from Cont. Operations Growth for CSL's Customers

You may also want to know
CSL's Annual Growth Rates CSL's Profitability Ratios CSL's Asset Turnover Ratio CSL's Dividend Growth
CSL's Roe CSL's Valuation Ratios CSL's Financial Strength Ratios CSL's Dividend Payout Ratio
CSL's Roa CSL's Inventory Turnover Ratio CSL's Growth Rates CSL's Dividend Comparisons



Companies with similar Income from Cont. Operations fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2023
Shockwave Medical Inc -0.05%$ -0.049 millions
Xeris Biopharma Holdings Inc -0.29%$ -0.295 millions
Tenet Healthcare Corp-0.75%$ -0.746 millions
U S Physical Therapy Inc-4.67%$ -4.672 millions
Universal Health Services Inc -4.98%$ -4.979 millions
National Research Corporation-5.09%$ -5.086 millions
Hca Healthcare Inc -5.13%$ -5.134 millions
Viatris Inc -6.41%$ -6.407 millions
Pacific Health Care Organization Inc -6.71%$ -6.710 millions
Mettler toledo International Inc -8.60%$ -8.598 millions
Corcept Therapeutics Inc-9.78%$ -9.777 millions
Charles River Laboratories International inc -9.83%$ -9.826 millions
Third Harmonic Bio Inc -10.51%$ -10.506 millions
The Pennant Group Inc -10.65%$ -10.653 millions
Henry Schein Inc-11.73%$ -11.728 millions
Quest Diagnostics Inc-14.13%$ -14.130 millions
Carlisle Companies Incorporated-15.01%$ -15.008 millions
Stryker Corp-15.20%$ -15.196 millions
Zimmer Biomet Holdings Inc -16.12%$ -16.117 millions
Amgen Inc -19.27%$ -19.272 millions
Entera Bio Ltd -22.43%$ -22.432 millions
Regeneron Pharmaceuticals Inc -23.40%$ -23.402 millions
Pediatrix Medical Group Inc -25.75%$ -25.746 millions
Zynex inc -26.25%$ -26.247 millions
Evofem Biosciences Inc -26.26%$ -26.256 millions
Tenax Therapeutics Inc -32.39%$ -32.386 millions
Avantor Inc -35.09%$ -35.090 millions
Ufp Technologies Inc -40.15%$ -40.154 millions
Bio techne Corp-43.17%$ -43.173 millions
Royalty Pharma Plc-44.61%$ -44.615 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com